Inventor
LONERGAN DAVID
US19 patents
⚠️ This page may combine multiple inventors who share the name “LONERGAN DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PHARMAKEA INC
11 patentsUS9334261B2May 10, 2016
Autotaxin inhibitor compounds
PHARMAKEA INC9 citations92
US9999615B2Jun 19, 2018
Autotaxin inhibitor compounds
PHARMAKEA INC6 citations83
US9468628B2Oct 18, 2016
Autotaxin inhibitor compounds
PHARMAKEA INC7 citations83
US10766860B2Sep 8, 2020
Lysyl oxidase-like 2 inhibitors and uses thereof
PHARMAKEA INC4 citations72
US10774069B2Sep 15, 2020
Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making
PHARMAKEA INC2 citations71
US9926318B2Mar 27, 2018
Tetracyclic autotaxin inhibitors
PHARMAKEA INC4 citations68
US11358936B2Jun 14, 2022
Lysyl oxidase-like 2 inhibitors and uses thereof
PHARMAKEA INC0 citations62
US11459309B2Oct 4, 2022
Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making
PHARMAKEA INC0 citations60
US9951026B2Apr 24, 2018
Heterocyclic vinyl autotaxin inhibitor compounds
PHARMAKEA INC1 citations51
US9850203B2Dec 26, 2017
Autotaxin inhibitor compounds
PHARMAKEA INC0 citations41
US9714240B2Jul 25, 2017
Vinyl autotaxin inhibitor compounds
PHARMAKEA INC0 citations40
SABRE THERAPEUTICS LLC
5 patentsUS10688081B2Jun 23, 2020
Autotaxin inhibitor compounds
SABRE THERAPEUTICS LLC4 citations83
US11779568B2Oct 10, 2023
Autotaxin inhibitor compounds
SABRE THERAPEUTICS LLC1 citations72
US11344533B2May 31, 2022
Autotaxin inhibitor compounds
SABRE THERAPEUTICS LLC3 citations72
US10632104B2Apr 28, 2020
Autotaxin inhibitors and uses thereof
SABRE THERAPEUTICS LLC4 citations68
US12268668B2Apr 8, 2025
Autotaxin inhibitor compounds
SABRE THERAPEUTICS LLC0 citations61